 Home > Biochemistry News > Biotechnology News > Next-Generation Anti-CTLA-4 mAb Receives FDA Fast Track Designation for the Treatment of Non-Small Cell Lung Cancer

Next-Generation Anti-CTLA-4 mAb Receives FDA Fast Track Designation for the Treatment of Non-Small Cell Lung Cancer

 Last Update: 2022-05-11
 Source: Internet
 Author: User

Tags

anti pd1 drugs

anti insulin antibody

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 26, OncoC4 announced that the U.

PD-1/L1 inhibitor-resistant non-small cell lung cancer is one of the clinical challenges of immunotherapy, and there is a huge unmet medical need

As a new generation of anti-CTLA-4 monoclonal antibody, ONC-392 can more effectively and selectively remove regulatory T cells in the tumor microenvironment, which is an important part of tumor immune escape The main "culprit"

Currently, ONC-392 is undergoing a Phase 1 clinical study overseas (PRESERVE-001 study) to evaluate its safety, pharmacokinetics, and efficacy as monotherapy and in combination with anti-PD-1 standard therapy in advanced solid tumors and NSCLC.

In China, OncorImmune is conducting a Phase 1 clinical study of ONC-392, which aims to evaluate the safety, tolerability and pharmacokinetics of the drug as a monotherapy for advanced solid tumors in the Chinese population

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.